Browse News

Found 636,589 articles

• Gannex Appoints Former Takeda Head of Liver Disease Clinical Development Melissa Palmer, MD as Chief Medical Officer

  11/30/2020

  Gannex, a wholly owned company of Ascletis Pharma Inc. and fully dedicated to the R&D and commercialization of new drugs in the field of NASH, announced that Melissa Palmer, MD, an internationally renowned Hepatologist, will join the Company as Chief Medical Officer, effective December 1, 2020.

• Toyoda Gosei Invests in Ball Wave, a Startup from Tohoku University

  11/30/2020

  Toyoda Gosei Co., Ltd. has invested1 in Ball Wave Inc., a startup from Tohoku University that develops practical applications of ball SAW sensors.2 These sensors use natural collimation of surface acoustic waves, a physical phenomenon predicted and experimentally verified by researchers at Tohoku University, and can instantly detect various kinds of matter in air and other gases at the nanoscale.

• Ascentage Pharma Enters into an Agreement with University of Michigan to obtain an exclusive license for a MDM2 Degrader using PROTAC Technology

  11/30/2020

  Ascentage Pharma announced it has entered into an agreement with the University of Michigan, through which the company may obtain the exclusive global rights to a MDM2 protein degrader developed using the Proteolysis-Targeting Chimeras technology.

• Telix Pharmaceuticals Limited Acquires TheraPharm GmbH, Broadening Reach to Hematologic Cancers and Transplant Medicine

  11/30/2020

  Telix Pharmaceuticals Limited announces it has entered into an agreement with Scintec Diagnostics GmbH to acquire TheraPharm GmbH, a Swiss-German biotechnology company developing innovative diagnostic and therapeutic solutions in the field of hematology.

• Sorrento to Participate in the 32nd Piper Sandler Healthcare Investor Conference

  11/30/2020

  Sorrento Therapeutics, Inc., is pleased to announce that Dr. Henry Ji, Chairman and CEO, will be participating in the Piper Sandler 32nd Annual Virtual Healthcare Conference.

• Canon Medical’s Compressed SPEEDER Helps Clinicians Reduce Scan Times for 3D MR Exams

  11/30/2020

  With the challenges of infectious diseases like COVID-19 and the ever-present financial pressure to increase throughput, it’s more important than ever before to scan faster.

• Canon Medical Introduces One-Beat Spectral Cardiac CT

  11/30/2020

  Aquilion ONE / PRISM Edition Now Offers Deep Learning Spectral Capabilities for Cardiac Exams

• Centene Provides Format Update Of Virtual 2021 Financial Guidance And Investor Meeting On December 18, 2020

  11/30/2020

  Centene Corporation provided an update on its upcoming 2021 Financial Guidance and Investor Meeting.

• Aesthetic Medical International Holdings Group Limited Reports Third Quarter 2020 Unaudited Financial Results

  11/30/2020

  Aesthetic Medical International Holdings Group Limited, a leading provider of aesthetic medical services in China, announces its unaudited financial results for the third quarter ended September 30, 2020.

• HOOKIPA Announces Positive Phase 2 Interim Safety, Immunogenicity, and Efficacy Data for its Cytomegalovirus Vaccine Candidate HB-101

  11/30/2020

  Early interim data show Cytomegalovirus (CMV)-negative kidney transplant recipients vaccinated with three doses of HB-101 had reduced incidence of CMV viremia, reduced antiviral use and no CMV disease

• Number of shares and votes in Oncopeptides - Nov 30, 2020

  11/30/2020

  Oncopeptides AB, a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases, announces that the number of shares and votes in Oncopeptides has changed due to the exercise of warrants under the company's incentive program.

• Forearm Fractures May Signal Intimate Partner Violence

  11/30/2020

  Up to one-third of adult women who sustain a non-displaced fracture to the ulna bone of the forearm may be victims of intimate partner violence, according to a study being presented at the annual meeting of the Radiological Society of North America.

• TeraRecon Launches NVIDIA-Powered Clinical Training Cloud for Global Education

  11/30/2020

  TeraRecon, the leading provider of AI-driven advanced visualization solutions, announced the debut of their Clinical Training Cloud for affordable imaging-based education initiatives across the US and Europe.

• Deep Learning Predicts Woman's Risk for Breast Cancer

  11/30/2020

  Researchers at Massachusetts General Hospital have developed a deep learning model that identifies imaging biomarkers on screening mammograms to predict a patient's risk for developing breast cancer with greater accuracy than traditional risk assessment tools.

• TeraRecon Expands Change Healthcare Distribution Agreement Adding AI Subscription

  11/30/2020

  TeraRecon, the leading provider of AI-driven advanced visualization solutions, announced the expansion of their distribution offering to Change Healthcare customers for their AI-powered Intuition Subscription.

• Zlatko Rihter assumes position as President and CEO of Mölnlycke

  11/30/2020

  He replaces interim CEO Barry McBride who reassumes his role as Executive Vice President Gloves, Antiseptics and Global R&D.

• New Studies Conclude Xlear Kills and/or Deactivates SARS-CoV-2

  11/30/2020

  New in vitro studies, led by renowned authority on respiratory diseases, conclude Xlear nasal spray is “an effective...and replicable means to deactivate SARS-CoV-2...to an undetectable amount of infectious virus.” This conclusion is “validated by two independent sets of experiments, performed by different labs, on different viral strains...” The Virucidal studies were independently funded.

• Charnwood Lighthouse Lab Goes Live Processing Thousands of COVID-19 Tests per Day with PerkinElmer Solutions

  11/30/2020

  UK’s newest Lighthouse Lab boosts the country’s COVID-19 testing capacity, while generating hundreds of new local jobs

• Nordic Nanovector announces change of its Oslo Børs ticker symbol to 'NANOV'

  11/30/2020

  Nordic Nanovector ASA announces that the Company's ticker symbol on the Oslo Børs will change from 'NANO' to 'NANOV' and will be effective as of the start of trading on 30 November 2020.

• Cytovance Biologics offers Nature Technology Corporation’s proprietary HyperGRO™ manufacturing platform for plasmid DNA CGMP manufacturing

  11/30/2020

  Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization of mammalian, microbial biologics and gene therapy plasmid DNA, announces a new agreement with Nature Technology Corporation for use of NTC’s proprietary HyperGRO™ manufacturing platform.